- Home
- 免费应用程序分析
- Drug Interactions with Updates
- Drug Interactions with Updates Vs. AHFS Drug Information
Drug Interactions with Updates 对比 AHFS Drug Information 的使用情况和统计数据
** Download the App to View a Free Video Preview **
ABOUT DRUG INTERACTIONS
The Drug Interactions app from The Medical Letter® provides users with an unbiased resource to quickly search and find potentially life-threatening interactions between multiple medications.
Start by searching for drugs by both generic and brand name and add them to a list has been built into the app. All known interactions between selected drugs can then be sorted alphabetically or by significance.
Detailed monographs about each interaction are provided so you can find recommendations for precautionary measures, links to supporting literature in PubMed, and much more. Drugs and interactions are updated regularly so you can always ensure safe drug administration and patient safety.
FEATURES
• Unbiased drug information – no advertising or pharmaceutical influence
• Regular updates
• Search box for locating interactions by generic and brand names
• Ability to create a list of multiple drugs and view all interactions
• Drug interactions sorted by significance or name
• Interaction details including precautionary measures, management, and more
• Lists of all interactions for any specific drug
• References with links to the supporting literature in PubMed
• Favorites for bookmarking important interactions
Note: Purchase includes 1-year subscription to Drug Interactions from The Medical Letter, which includes regular updates.
CONTENT UPDATE RENEWAL
• Purchase includes a 1-year subscription with regular content updates. Your subscription will be automatically renewed for $49.99 at the end of your 1-year term, unless you turn off auto-renew. If you do not choose to renew, you can continue to use the product but will not receive updates.
• This app will automatically renew annually at the current renewal rate ($49.99) and charged to your iTunes account at confirmation of purchase, unless auto-renew is turned off 24 hours prior to the conclusion of the one-year subscription period.
• Subscriptions may be managed by the user and auto-renewal may be turned off by going to the user's Account Settings after purchase.
Editor in Chief: Jean-Marie Pflomm, Pharm.D.; Susan Daron, Pharm.D.; Corinne Morrison, Pharm.D.; Michael Viscusi, Pharm.D.
Publisher: The Medical Letter®
Powered by: Unbound Medicine
UPGRADE OPTION
Add Davis’s Drug Guide to your Drug Interactions from The Medical Letter app. After purchase, you can easily add a 1-year subscription of the best-selling drug database trusted by thousands of healthcare professionals. Davis’s Drug Guide delivers frequently updated information on over 5,000 trade name and generic drugs. Each monograph, with its focus on safety, includes details on pharmacokinetics, dosing, side effects, interactions, assessment, and more.
Your Davis’s Drug Guide subscription automatically renews annually unless auto-renew is turned off 24 hours prior to the conclusion of your current period. Your iTunes account will automatically be charged the current renewal rate ($39.99) within 24 hours prior to the end of the subscription period. This will ensure you receive all updates for the following year. Subscriptions may be managed by the user and auto-renewal may be turned off by going to the user's Account Settings after purchase.
Unbound Privacy Policy: www.unboundmedicine.com/privacy
Unbound Terms of Use: https://www.unboundmedicine.com/end_user_license_agreement
- Apple 应用商店
- 免费
- 医疗
商店排名
- -
"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.
AHFS® Drug Information™ - Doody's Core Title - is your comprehensive, interactive treatment and drug therapy solution - complete with therapeutic guidelines and off-label uses.
2020, 2021, 2022, 2023, 2024 Doody's Core Titles List Selection
AHFS Drug Information® 2025 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.
With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice.
Updates in the new edition:
- Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines
- Expanded coverage of specialty medications used to treat a variety of complex, chronic conditions that often require special handling and administration and may require careful oversight to manage severe adverse effects and dosage adjustments
- Contemporary topics such as vaccines and treatments for mPox disease, new RSV treatments and vaccines, safety issues associated with the glucagon-like peptide 1 (GLP-1) agonists, novel orphan drugs, biosimilars, and more
- Expanded content on new and emerging gene therapies
- Pharmacogenomic considerations in drug dosing and selection
- Updates to a variety of vaccine monographs including the influenza, COVID-19, pneumococcal, and RSV vaccines with the latest recommendations from the CDC Advisory Committee on Immunization Practices (ACIP)
- Expanded content on off-label uses, real world data and long-term clinical data
- MedWatch alerts, Standardize4Safety concentration standards for IV and oral liquid medications, REMS data, and focused updates based on FDA safety findings
- New content on over 200 new molecular entities (NMEs) or new therapeutic biological products and substantive revisions on approximately 265 medications
- Oncology off-label determinations based on reviews by the AHFS Oncology Expert Committee
Content licensed from printed ISBN 10: 158528761X
Content licensed from printed ISBN 13: 9781585287611
SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.
Yearly auto-renewing payments- $99.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable."
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
https://www.skyscape.com/index/privacy.aspx
Editor(s): American Society of Health-System Pharmacists, Inc.
Publisher: American Society of Health-System Pharmacists, Inc.
- Apple 应用商店
- 免费
- 医疗
商店排名
- -
Drug Interactions with Updates与AHFS Drug Information排名比较
对比 Drug Interactions with Updates 与 AHFS Drug Information 在过去 28 天内的排名趋势
排名
没有可用的数据
Drug Interactions with Updates 对比 AHFS Drug Information 的排名,按国家/地区比较
对比 Drug Interactions with Updates 与 AHFS Drug Information 在过去 28 天内的排名趋势
所有品类
没有可用的数据
医疗
通过免费试用版比较任何网站


三月 19, 2025